drugset / Trial / NCT03552016

Evaluation of Progression of Myopia in Children Treated With Vitamin B2 and Outdoor Sunlight Exposure

NCT03552016

Phase 2 Suspended 100 enrolled University of Missouri-Columbia
RandomizedSingle-groupTriple-blindTreatment

Summary

The investigators plan on using riboflavin (a Vitamin that can easily be taken orally each day) and having the children involved in the study play outside (where there is UV light created by the sun) in order to prevent the eye from becoming progressively more near-sighted.

Timeline

Start
2018-10-10
Primary completion
2029-10-10
Completion
2030-10-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Riboflavin Other / unclassified 200 mg Oral
Subject Riboflavin Other / unclassified 400 mg Oral

Indications